Order your BioIndustry Review
The BioIndustry Review is only available in paperback and the price includes worldwide shipping. To place your order by fax or post, download an Order Form (0.51Mb PDF).
2008 BioIndustry Review: Australia and New Zealand
Paperback: 118 Pages, 26 Tables and 31 Graphs
Price: AU$275 (Including 10% GST if in Australia)
To be relaeased on 21 Feburary 2008
Pre-Order using our Order Form.
The 2008 BioIndustry Review includes:
• Data, statistics and trends in the Australian and New Zealand bioindustry
• Exclusive information and analysis on Australia’s unlisted companies
• Analysis of new Australian and New Zealand biotech startups for 2006/07
• Update in drug development activity
• Federal and State Government activity and funding in Australia in 2006/07
• What have been the major regulatory changes in Australia & New Zealand in 2007?
• Outlook for 2008
This year’s feature focus: business models and biotech company growth.
2007 BioIndustry Review: Australia and New Zealand
Paperback: 104 Pages, 32 Tables and 34 Graphs
Price: AU$249 (Including 10% GST if in Australia)
Click here for the table of contents and a list of tables and figures (0.16Mb PDF).
The 2007 BioIndustry Review includes:
• Data, statistics and trends in the Australian and New Zealand bioindustry
• Exclusive information and analysis on Australia’s unlisted companies
• Analysis of new Australian and New Zealand biotech startups for 2005/06
• What is the economic impact of biotech?
• Federal and State Government activity and funding in Australia in 2005/06
• What have been the major regulatory changes in Australia & New Zealand in 2006?
• Outlook for 2007
2006 BioIndustry Review: Australia and New Zealand
Paperback: 87 Pages, 41 Tables and 17 Graphs
Price: AU$215 (Including 10% GST if in Australia)
Click
here for the table of contents and a list of tables and figures (0.15Mb PDF).
The 2006 BioIndustry Review includes:
• Data, statistics and trends in the Australian and New Zealand bioindustry
• Exclusive information and analysis on Australia’s unlisted companies
• Analysis of new Australian and New Zealand biotech startups for 2004/05
• Analysis of the drug development pipeline in Australia
• Federal and State Government activity and funding in Australia in 2004/05
• Outlook for 2006
2005 BioIndustry Review: Australia and New Zealand
Paperback: 90 Pages, 35 Tables and 43 Graphs
Price: AU$215 (Including 10% GST if in Australia)
Click
here for the table of contents and a list of tables and figures (0.02Mb PDF).
The 2005 BioIndustry Review includes:
• Data, statistics and trends in the Australian and New Zealand bioindustry with information and analysis not otherwise available on Australia’s unlisted companies
• Analysis of the drug development pipeline in Australia
• Analysis of listed companies’ performance as they progress in drug development pipeline
• Analysis of new Australian and New Zealand biotech startups for 2003/04
• Federal and State Government activity and funding in Australia in 2003/04
• Comparison of Australian industry to the biotech activities in the Asia Pacific
• Outlook for 2005
2005/06/07 BioIndustry Review: Australia and New Zealand - 3 Pack
Get your hands on 3 years of Trends and Analysis.
Price: AU$500 (Including 10% GST if in Australia)
2001/2/3/5/6 BioIndustry Review: Australia and New Zealand - 5 Pack
Get your hands on 5 years of Trends and Analysis.
Price: AU$700 (Including 10% GST if in Australia)
Latest News
Australian Drug Development Surges Ahead full story...
Production of the 2008 BioIndustry Review underway full story...
2007 BioIndustry Review: Australia and New Zealand released full story...
Recommendations
"The BioIndustry Review is one of the few worthwhile fact bases in the industry. It is unique because it covers both public and private companies."
Dr Michael Hirshorn, Director, Kestrel Capital
"The BIR continues to be an excellent source of review and trend analysis within the Australian biomedical industry." Dr Ashley Bates, Head of Research, GlaxoSmithKline
"Innovation Dynamics BioIndustry Review has allowed us to keep track of the progress and changes occurring within the Australasian industry." Dr Brian Ward, CEO, NZBio